Pasar al contenido principal
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
En afiliación con HIV.gov
Main navigation
  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Español (Spanish)
  • English
  1. Inicio
  2. Guidelines search

Búsqueda de Guías

  • Perinatal HIV Clinical Guidelines (41)
  • HIV Clinical Guidelines: Adult and Adolescent ARV (36)
  • HIV Clinical Guidelines: Pediatric ARV (36)
  • HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (14)
  • HIV Clinical Guidelines: Pediatric Opportunistic Infections (6)
  • Guidance for Caring for People With HIV Displaced by Disasters (2)
Resultados de la búsqueda 1 – 20 de 135
What's New in the Guidelines
… B and HIV when prescribing ARV regimens that do not include tenofovir. Added the two-drug ARV regimen doravirine … D virus infection. Clarified that, in certain situations, tenofovir alafenamide (TAF) or tenofovir disoproxil fumarate (TDF) alone (without 3TC or …
Guidance for Non-HIV-Specialized Providers Caring for People With HIV Who Have Been Displaced by Disasters (Such as a Hurricane)
… some nucleoside reverse transcriptase inhibitors, including tenofovir disoproxil fumarate or tenofovir alafenamide, emtricitabine, or lamivudine. These …
What's New in the Guidelines
… isolated anti–hepatitis B core antibody to reflect that tenofovir-sparing regimens can also be considered with …
What's New in the Guidelines
… Therapy During Pregnancy Bictegravir (BIC) plus tenofovir alafenamide (TAF) plus FTC (available as the … now include BIC plus TAF plus FTC  or  DTG plus (TAF or tenofovir disoproxil fumarate [TDF]) plus (FTC or 3TC). For …
What's New in the Guidelines
… reverse transcriptase inhibitors, (i.e., tenofovir disoproxil fumarate or tenofovir alafenamide [TAF] with 3TC or FTC; ABC and 3TC). …
Appendix C: Antiretroviral Medications That Can Be Switched Temporarily If Unable to Access Certain Formulations
… Names) Replace With – Brand (Generic 1 ) Names Efavirenz + tenofovir DF + emtricitabine (generic single tablet regimen) Generic efavirenz + Truvada (tenofovir DF + emtricitabine 2 ) or Generic efavirenz + Descovy (tenofovir alafenamide + emtricitabine) or Generic (efavirenz …
Candida Infections
… but itraconazole may increase exposures and AEs from tenofovir disoproxil fumarate and tenofovir alafenamide. Most integrase strand transferase …
Preventing HIV Transmission During Infant Feeding
… infant. 92 NRTIs show more variability than PIs and NNRTIs. Tenofovir concentrations from tenofovir disoproxil fumarate (TDF) are very low in breast … Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk …
Pre-exposure Prophylaxis (PrEP) to Prevent HIV During Periconception, Antepartum, and Postpartum Periods
… HIV prevention option for the individual patient (AIII). Tenofovir disoproxil fumarate plus emtricitabine is … are pregnant, postpartum, or breastfeeding. 3 Combination tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) as … regarding the risk of possible hepatitis flares when tenofovir-based PrEP is stopped. 36 See Hepatitis B …
Principles of Antiretroviral Therapy
… latter typically being treated with a regimen that includes tenofovir with or without emtricitabine or lamivudine (or uses entecavir with an active non-tenofovir-containing ARV regimen) (see Hepatitis B Virus/HIV …
Laboratory Testing for Initial Assessment and Monitoring of People With HIV
… infection; PR = protease; RT = reverse transcriptase; TAF = tenofovir alafenamide; TDF = tenofovir disoproxil fumarate References Horberg M, Thompson …
Laboratory Testing: Plasma HIV-1 RNA (Viral Load) and CD4 Count Monitoring
… therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens. …
Laboratory Testing: Drug-Resistance Testing
… and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in … . Pozniak AL, Gallant JE, DeJesus E, et al. Tenofovir disoproxil fumarate, emtricitabine, and efavirenz …
Baseline Evaluation
… a regimen with activity against hepatitis B virus (i.e., tenofovir alafenamide or tenofovir disoproxil fumarate with emtricitabine or …
Overview
… Transfer Inhibitors (INSTIs) Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Dosing … RPV = rilpivirine; RTV = ritonavir; TAF = tenofovir alafenamide; TDF = tenofovir disoproxil fumarate Sources: Panel on …
COVID-19
… of HIV (e.g., lopinavir/‌ritonavir, boosted darunavir, or tenofovir disoproxil fumarate/emtricitabine) have efficacy …
Antiretroviral Drug Resistance and Resistance Testing in Pregnancy
… patients receiving elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide for 144 weeks. J Clin Virol . …
Clinical and Laboratory Monitoring of Pediatric HIV Infection
… HgbA1C = glycosylated hemoglobin; RPV = rilpivirine; TAF = tenofovir alafenamide; TB = tuberculosis; TDF = tenofovir disoproxil fumarate Table 7. Primary U.S. Food and …
Treatment Goals
… Lazzarin A, Mills A, et al. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and … al. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in …
What to Start: Initial Combination Antiretroviral Regimens
… transfer inhibitor; PrEP = pre-exposure prophylaxis; TAF = tenofovir alafenamide; TDF = tenofovir disoproxil fumarate; TFV = tenofovir Table 6b. Initial Antiretroviral Regimens for …

Paginación

  • Página actual 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • …
  • Siguiente página ›
  • Última página ››

Conéctese con nosotros

Footer menu

  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Patrocinadores
  • Aviso de no discriminación
  • Accesibilidad
  • El descargo de responsabilidad
  • Mapa del sitio
  • Declaración de privacidad
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Ley de Acceso a Información

Proporcionado en colaboración con la Oficina de Investigación del SIDA de los NIH.